Uptake and Persistence on HIV Pre-Exposure Prophylaxis Among Female Sex Workers and Men Having Sex with Men in Kigali, Rwanda: A Retrospective Cross-Sectional Study Design

References

• Bekker LG, Giovenco D, Baral S, et al. Oral pre-exposure prophylaxis uptake, adherence, and adverse events among South African men who have sex with men and transgender women. South Afr J HIV Med. 2022;23(1):1–9. doi:10.4102/SAJHIVMED.V23I1.1405
   Google Scholar
• Kagaayi J, Batte J, Nakawooya H, et al. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda. J Int AIDS Soc. 2020;23(8):1–6. doi:10.1002/jia2.25588
   Web of Science ®Google Scholar
• Fonner VA, Dalglish SL, Kennedy CE, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. Aids. 2016;30(12):1973–1983. doi:10.1097/QAD.0000000000001145
   PubMed Web of Science ®Google Scholar
• Pre-Exposure Prophylaxis (PrEP). Centers for disease control and prevention; 2023. Available from: https://www.cdc.gov/hiv/risk/prep/index.html#:~:text=Pre-exposureprophylaxis. Accessed September 15, 2023.
   Google Scholar
• Saing CH, Prem K, Uk P, et al. Risk factors associated with HIV and hepatitis C virus co-infection among people who inject drugs in Cambodia. Int J Drug Policy. 2020;86:1–11. doi:10.1016/j.drugpo.2020.102974
   Web of Science ®Google Scholar
• World Health Organization. HIV/AIDS; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Accessed September 15, 2023.
   Google Scholar
• Bbosa N, Kaleebu P, Ssemwanga D. HIV subtype diversity worldwide. Curr Opin HIV AIDS. 2019;14(3):153–160. doi:10.1097/COH.0000000000000534
   PubMed Web of Science ®Google Scholar
• Shao Y, Williamson C. The HIV-1 epidemic: low- to middle-income countries. Cold Spring Harb Perspect Med. 2012;2(3):a007187. doi:10.1101/cshperspect.a007187
   PubMed Web of Science ®Google Scholar
• Gengiah TN, Moosa A, Naidoo A, Mansoor LE. Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection. Int J Clin Pharm. 2014;36(1):0–85. doi:10.1007/s11096-013-9861-1
   Web of Science ®Google Scholar
• Stalter R, Chen M, Uwizeye G, et al. Association of sexual risk behaviour with previous HIV testing among VCT clients in Kigali, Rwanda. Int J STD AIDS. 2015;27(14):1317–1325. doi:10.1177/0956462415617590
   PubMed Web of Science ®Google Scholar
• Uganda Ministry of Health. Consolidated Guidelines for Prevention and Treatment of HIV. Uganda Ministry of Health; 2016.
   Google Scholar
• Mboup A, Béhanzin L, Guédou FA, et al. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study. J Int AIDS Soc. 2018;21(11):1–11. doi:10.1002/jia2.25208
   Web of Science ®Google Scholar
• Jourdain H, de Gage SB, Desplas D, Dray-Spira R. Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control study. Lancet Public Heal. 2022;7(6):e529–e536. doi:10.1016/S2468-2667(22)00106-2
   PubMed Web of Science ®Google Scholar
• World Health Organization. Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations – 2016 Update. World Health Organization; 2016:155.
   Google Scholar
• Chou R, Evans C, Hoverman A, et al. Preexposure prophylaxis for the prevention of HIV infection: evidence report and systematic review for the US preventive services task force. JAMA. 2019;321(22):2214–2230. doi:10.1001/jama.2019.2591
   PubMed Web of Science ®Google Scholar
• Havens JP, Scarsi KK, Sayles H, Klepser DG, Swindells S, Bares SH. Acceptability and feasibility of a pharmacist-led human immunodeficiency virus pre-exposure prophylaxis program in the Midwestern United States. Open Forum Infect Dis. 2019;6(10). doi:10.1093/ofid/ofz365
   PubMed Web of Science ®Google Scholar
• Gombe MM, Cakouros BE, Ncube G, et al. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: qualitative perspectives of general population clients at high risk for HIV. PLoS One. 2020;15(1):1–18. doi:10.1371/journal.pone.0227632
   Web of Science ®Google Scholar
• Shannon K, Crago AL, Baral SD, et al. The global response and unmet actions for HIV and sex workers. Lancet. 2018;392(10148):698–710. doi:10.1016/S0140-6736(18)31439-9
   PubMed Web of Science ®Google Scholar
• Greenwald ZR, Maheu-Giroux M, Szabo J, et al. Cohort profile: L’Actuel Pre-Exposure Prophylaxis (PrEP) Cohort study in Montreal, Canada. BMJ Open. 2019;9(6):1–10. doi:10.1136/bmjopen-2018-028768
   PubMedGoogle Scholar
• Jackson-gibson M, Ezema AU, Orero W, et al. Facilitators and barriers to HIV pre- exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya. BMC Public Health. 2021;21:1–13. doi:10.1186/s12889-021-11335-1
   PubMed Web of Science ®Google Scholar
• Pillay D, Stankevitz K, Lanham ML, et al. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa. PLoS One. 2020;15(4):e0228620. doi:10.1371/journal.pone.0228620
   PubMed Web of Science ®Google Scholar
• UNAIDS. Countries as diverse as Italy, Lesotho, Viet Nam and Zimbabwe cut new HIV infections by more than 45% between 2015 and 2021: UNAIDS GLOBAL AIDS UPDATE; 2022. Available from: https://www.unaids.org/sites/default/files/media_asset/2022-global-aids-update-summary_en.pdf. Accessed September 15, 2023.
   Google Scholar
• Koppe U, Marcus U, Albrecht S, et al. Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany. BMC Public Health. 2021;21(159):1–10. doi:10.1186/s12889-021-10174-4
   PubMedGoogle Scholar
• Hojilla JC, Koester K, Cohen S, et al. Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: a qualitative analysis of counseling notes. AIDS Behav. 2016;20(7):1461–1469. doi:10.1007/s10461-015-1055-5
   PubMed Web of Science ®Google Scholar
• van Dijk M, de Wit JBF, Guadamuz TE, Martinez JE, Jonas KJ. Slow Uptake of PrEP: behavioral predictors and the influence of price on prep uptake among MSM with a high interest in PrEP. AIDS Behav. 2021;25(8):2382–2390. doi:10.1007/s10461-021-03200-4
   PubMed Web of Science ®Google Scholar
• Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, et al. Defining the HIV pre-exposure prophylaxis care continuum. Aids. 2017;31(5):731–734. doi:10.1097/QAD.0000000000001385
   PubMed Web of Science ®Google Scholar
• Koss CA, Charlebois ED, Ayieko J, et al. Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study. Lancet HIV. 2020;7(4):e249–e261. doi:10.1016/S2352-3018(19)30433-3
   PubMed Web of Science ®Google Scholar
• Ahouada C, Diabaté S, Mondor M, et al. Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin. BMC Public Health. 2020;20(1):1–17. doi:10.1186/s12889-020-09363-4
   PubMed Web of Science ®Google Scholar
• Muhumuza R, Ssemata AS, Kakande A, et al. Exploring perceived barriers and facilitators of PrEP uptake among young people in Uganda, Zimbabwe, and South Africa. Arch Sex Behav. 2021;50(4):1729–1742. doi:10.1007/s10508-020-01880-y
   PubMed Web of Science ®Google Scholar
• Beesham I, Milford C, Smit J, et al. Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa. BMC Public Health. 2023;23(1):1–11. doi:10.1186/s12889-023-16139-z
   PubMed Web of Science ®Google Scholar
• Skovdal M, Magoge-Mandizvidza P, Dzamatira F, et al. Improving access to pre-exposure prophylaxis for adolescent girls and young women: recommendations from healthcare providers in eastern Zimbabwe. BMC Infect Dis. 2022;22(1):1–10. doi:10.1186/s12879-022-07376-5
   PubMed Web of Science ®Google Scholar
• Gueler A, Vanobberghen F, Rice B, Egger M, Mugglin C. The HIV Care Cascade from HIV diagnosis to viral suppression in sub-Saharan Africa: a systematic review and meta-regression analysis protocol. Syst Rev. 2017;6(1):1–6. doi:10.1186/s13643-017-0562-z
   PubMedGoogle Scholar
• Spriggs M, Charles T. Should HIV discordant couples have access to assisted reproductive technologies? J Med Ethics. 2003;29(6):325–329. doi:10.1136/jme.29.6.325
   PubMed Web of Science ®Google Scholar
• Ba G, Malonza J, Manirakiza V. Understanding the Concept of Neighbourhood in Kigali City, Rwanda. Sustainability. 2020;12(1555):1–22. doi:10.3390/su12041555
   PubMedGoogle Scholar
• Rwanda Biomedical Center. Prevalence and factors associated with preterm birth at Kenyatta National Hospital. Enferm Glob. 2018;18(1):1–15. doi:10.6018/eglobal.16.3.255721
   Google Scholar
• Twarabamenye E, Mukashema A. Long-run trend of cities’ informal housing: a solution for the majority of Kigali Urban Dwellers and a Challenge to Urban Development in Rwanda. J Environ Manag. 2012;3:35–56.
   Google Scholar
• Nduwayezu G, Sliuzas R, Kuffer M. Modeling urban growth in Kigali city Rwanda. Rwanda J. 2017;1(2). doi:10.4314/rj.v1i2S.7D
   Google Scholar
• FHAPCO. Rwanda country operational plan (COP/ROP) 2018 strategic direction summary; 2018. Available from: https://www.state.gov/wp-content/uploads/2019/08/Rwanda-2.pdf. Accessed September 15, 2023.
   Google Scholar
• National Institute of statistics of Rwanda (NISR) [Rwanda], Ministry of Health (MoH) [Rwnda], ICF. Rwanda demographic and health survey 2019–20 key indicators report. Natioanal Institute of Statistics of Rwanda; 2020. Available from: https://www.statistics.gov.rw/datasource/demographic-and-health-survey-201920. Accessed September 15, 2023.
   Google Scholar
• Nsanzimana S, Rwibasira GN, Malamba SS, et al. HIV incidence and prevalence among adults aged 15–64 years in Rwanda: results from the Rwanda Population-based HIV Impact Assessment (RPHIA) and District-level Modeling, 2019. Int J Infect Dis. 2022;116:245–254. doi:10.1016/j.ijid.2022.01.032
   PubMed Web of Science ®Google Scholar
• Shrestha B, Dunn L. The declaration of Helsinki on medical research involving human subjects: a review of seventh revision. J Nepal Heal Res Counc. 2020;17(4):548–552. doi:10.33314/jnhrc.v17i4.1042
   PubMedGoogle Scholar
• Rao A, Mhlophe H, Comins C, et al. Persistence on oral pre-exposure prophylaxis (PrEP) among female sex workers in eThekwini, South Africa, 2016–2020. PLoS One. 2022;17(3):e0265434. doi:10.1371/journal.pone.0265434
   PubMed Web of Science ®Google Scholar
• Irungu EM, Mugwanya KK, Mugo NR, et al. Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial. Lancet Glob Heal. 2021;9(12):e1730–e1739. doi:10.1016/S2214-109X(21)00391-0
   PubMed Web of Science ®Google Scholar
• Sarr M, Gueye D, Mboup A, et al. Uptake, retention, and outcomes in a demonstration project of pre-exposure prophylaxis among female sex workers in public health centers in Senegal. Int J STD AIDS. 2020;31(11):1063–1072. doi:10.1177/0956462420943704
   PubMed Web of Science ®Google Scholar
• Donnell D, Beesham I, Welch JD, et al. Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study. Lancet HIV. 2021;8(8):e495–e501. doi:10.1016/S2352-3018(21)00048-5
   PubMed Web of Science ®Google Scholar
• Rolle CP, Rosenberg ES, Siegler AJ, et al. Challenges in translating PrEP interest into uptake in an observational study of young black MSM. J Acquir Immune Defic Syndr. 2017;76(3):250. doi:10.1097/QAI.0000000000001497
   PubMed Web of Science ®Google Scholar
• Wang Z, Mo PKH, Ip M, Fang Y, Lau JTF. Uptake and willingness to use PrEP among Chinese gay, bisexual and other men who have sex with men with experience of sexualized drug use in the past year. BMC Infect Dis. 2020;20:1–13.
   Web of Science ®Google Scholar
• Eakle R, Gomez GB, Naicker N, et al. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: results from a prospective observational demonstration project. PLoS Med. 2017;14(11):e1002444. doi:10.1371/journal.pmed.1002444
   PubMed Web of Science ®Google Scholar
• Chan PA, Mena L, Patel R, et al. Retention in care outcomes for HIV pre‐exposure prophylaxis implementation programmes among men who have sex with men in three US cities. J Int AIDS Soc. 2016;19(1):20903. doi:10.7448/IAS.19.1.20903
   PubMedGoogle Scholar
• Wahome EW, Graham SM, Thiong’o AN, et al. PrEP uptake and adherence in relation to HIV-1 incidence among Kenyan men who have sex with men. EClinicalMedicine. 2020;26:100541. doi:10.1016/j.eclinm.2020.100541
   PubMedGoogle Scholar
• Chan PA, Patel RR, Mena L, et al. Long-term retention in pre-exposure prophylaxis care among men who have sex with men and transgender women in the United States. J Int AIDS Soc. 2019;22(8):1–9. doi:10.1002/jia2.25385
   Web of Science ®Google Scholar
• Wanga V, Omollo V, Bukusi EA, et al. Uptake and impact of facility-based HIV self-testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya. J Int AIDS Soc. 2020;23(8):14–18. doi:10.1002/jia2.25561
   Web of Science ®Google Scholar
• Ojikutu BO, Bogart LM, Higgins-Biddle M, et al. Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) use among black individuals in the United States: results from the national survey on HIV in the black community (NSHBC). AIDS Behav. 2018;22(11):3576–3587. doi:10.1007/s10461-018-2067-8
   PubMed Web of Science ®Google Scholar
• Morgan E, Moran K, Ryan DT, Mustanski B, Newcomb ME. Threefold increase in PrEP uptake over time with high adherence among young men who have sex with men in Chicago. AIDS Behav. 2018;22(11):3637–3644. doi:10.1007/s10461-018-2122-5
   PubMed Web of Science ®Google Scholar
• Rubtsova AM, Wingood G, Dunkle K, Camp CJ, DiClemente R. Young adult women and correlates of potential adoption of pre-exposure prophylaxis (PrEP): results of a national survey. Curr HIV Res. 2013;11(7):543–548. doi:10.2174/1570162X12666140129104952
   PubMed Web of Science ®Google Scholar
• Chapin-Bardales J, Haaland R, Martin A, et al. HIV pre-exposure prophylaxis persistence and adherence among men who have sex with men in four US Cities. JAIDS J Acquir Immune Defic Syndr. 2013;91(3):34–41. doi:10.1097/QAI.0000000000003160
   Google Scholar
• Cahill S, Taylor S, Elsesser S, Mena L, Hickson D, Mayer K. Stigma, medical mistrust, and perceived racism may affect PrEP awareness and uptake in black compared to white gay and bisexual men in Jackson, Mississippi and Boston, Massachusetts. AIDS Care. 2021;29(11):1351–1358. doi:10.1080/09540121.2017.1300633
   Google Scholar